Literature DB >> 29253114

Informatics for cancer immunotherapy.

J Hammerbacher1,2, A Snyder3,4.   

Abstract

The rapid development of immunomodulatory cancer therapies has led to a concurrent increase in the application of informatics techniques to the analysis of tumors, the tumor microenvironment, and measures of systemic immunity. In this review, the use of tumors to gather genetic and expression data will first be explored. Next, techniques to assess tumor immunity are reviewed, including HLA status, predicted neoantigens, immune microenvironment deconvolution, and T-cell receptor sequencing. Attempts to integrate these data are in early stages of development and are discussed in this review. Finally, we review the application of these informatics strategies to therapy development, with a focus on vaccines, adoptive cell transfer, and checkpoint blockade therapies.
© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adoptive cell transfer; bioinformatics; checkpoint blockade; computational biology; immunotherapy; neoantigens

Mesh:

Year:  2017        PMID: 29253114      PMCID: PMC5834022          DOI: 10.1093/annonc/mdx682

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  395 in total

Review 1.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 2.  T cell subsets and the recognition of MHC class.

Authors:  S L Swain
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

3.  SomaticSniper: identification of somatic point mutations in whole genome sequencing data.

Authors:  David E Larson; Christopher C Harris; Ken Chen; Daniel C Koboldt; Travis E Abbott; David J Dooling; Timothy J Ley; Elaine R Mardis; Richard K Wilson; Li Ding
Journal:  Bioinformatics       Date:  2011-12-06       Impact factor: 6.937

Review 4.  Somatic clonal evolution: A selection-centric perspective.

Authors:  Jacob Scott; Andriy Marusyk
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-02       Impact factor: 10.680

5.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

6.  Estimation of rearrangement phylogeny for cancer genomes.

Authors:  Chris D Greenman; Erin D Pleasance; Scott Newman; Fengtang Yang; Beiyuan Fu; Serena Nik-Zainal; David Jones; King Wai Lau; Nigel Carter; Paul A W Edwards; P Andrew Futreal; Michael R Stratton; Peter J Campbell
Journal:  Genome Res       Date:  2011-10-12       Impact factor: 9.043

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.

Authors:  F Favero; T Joshi; A M Marquard; N J Birkbak; M Krzystanek; Q Li; Z Szallasi; A C Eklund
Journal:  Ann Oncol       Date:  2014-10-15       Impact factor: 32.976

9.  DELLY: structural variant discovery by integrated paired-end and split-read analysis.

Authors:  Tobias Rausch; Thomas Zichner; Andreas Schlattl; Adrian M Stütz; Vladimir Benes; Jan O Korbel
Journal:  Bioinformatics       Date:  2012-09-15       Impact factor: 6.937

10.  Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non-Small-cell Lung Cancer.

Authors:  Charlotte Roach; Nancy Zhang; Ellie Corigliano; Malinka Jansson; Grant Toland; Gary Ponto; Marisa Dolled-Filhart; Kenneth Emancipator; Dave Stanforth; Karina Kulangara
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-07
View more
  2 in total

1.  TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology.

Authors:  Zhihong Liu; Chuipu Cai; Jiewen Du; Bingdong Liu; Lu Cui; Xiude Fan; Qihui Wu; Jiansong Fang; Liwei Xie
Journal:  Front Pharmacol       Date:  2020-04-15       Impact factor: 5.810

2.  A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors.

Authors:  Xiao-Li Wei; Chao Ren; Feng-Hua Wang; Yang Zhang; Hong-Yun Zhao; Ben-Yan Zou; Zhi-Qiang Wang; Miao-Zhen Qiu; Dong-Sheng Zhang; Hui-Yan Luo; Feng Wang; Sheng Yao; Rui-Hua Xu
Journal:  Cancer Commun (Lond)       Date:  2020-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.